Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (141)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Larotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Larotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Repotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Repotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ensartinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Ensartinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Iruplinalkib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Iruplinalkib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Taletrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Taletrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Sunitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Sunitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sorafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Sorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pazopanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Pazopanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Axitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Axitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Regorafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Regorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cabozantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lenvatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Lenvatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

Larotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Repotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ensartinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Iruplinalkib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Taletrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Sunitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Pazopanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Axitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Regorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lenvatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

‹ 1 2 3 4 5 … 12 ›

Product Range

Company

Global Network

Products

Larotrectinib

Repotrectinib

Ensartinib

Iruplinalkib

Taletrectinib

Sunitinib

Sorafenib

Pazopanib

Axitinib

Regorafenib

Cabozantinib

Lenvatinib

Larotrectinib

Repotrectinib

Ensartinib

Iruplinalkib

Taletrectinib

Sunitinib

Sorafenib

Pazopanib

Axitinib

Regorafenib

Cabozantinib

Lenvatinib